- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 39/04 - Chelating agents
Patent holdings for IPC class A61P 39/04
Total number of patents in this class: 197
10-year publication summary
|
6
|
7
|
10
|
8
|
5
|
8
|
11
|
11
|
14
|
10
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Centre National de La Recherche Scientifique | 10706 |
10 |
| The Regents of the University of California | 20303 |
8 |
| Uop LLC | 4259 |
6 |
| Universite Claude Bernard Lyon 1 | 1041 |
5 |
| Mexbrain | 28 |
5 |
| Chelation Partners Incorporated | 8 |
4 |
| Universite de Bretagne Occidentale | 109 |
4 |
| AustinPx, LLC | 28 |
4 |
| Cornell University | 3361 |
3 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3374 |
3 |
| Institut Curie | 608 |
3 |
| Institut Gustave Roussy | 272 |
3 |
| University of Kansas | 894 |
3 |
| The University of Sydney | 610 |
3 |
| Fe Pharmaceuticals (Canada) Inc. | 5 |
3 |
| Novartis AG | 10612 |
2 |
| Murata Manufacturing Co., Ltd. | 25020 |
2 |
| The Board of Trustees of the University of Illinois | 2724 |
2 |
| University of Florida Research Foundation, Inc. | 4089 |
2 |
| Apotex Technologies Inc. | 16 |
2 |
| Other owners | 120 |